According to a newly published market research report by 24LifeSciences, global drugs for brucellosis market was valued at USD 120 million in 2024 and is projected to reach USD 198 million by 2032, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period 2025–2032. Brucellosis, a zoonotic infection caused by Brucella species (primarily B. melitensis, B....